Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Astellas Institute for Regenerative Medicine”

30 pharma patents match "Astellas Institute for Regenerative Medicine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 30
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 30 pharmaceutical patents matching "Astellas Institute for Regenerative Medicine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

30 results for “Astellas Institute for Regenerative Medicine” · 30,257 patents in full index Clear search

  1. US 12419958

    Clinical formulations

    Astellas Institute for Regenerative Medicine · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12209255

    Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

    Astellas Institute for Regenerative Medicine · Granted Jan 28, 2025 · Expires Jan 23, 2045

    granted
  3. US 12109239

    Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  4. US 12097223

    Mesenchymal stromal cells and uses related thereto

    Astellas Institute for Regenerative Medicine · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  5. US 12076347

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  6. US 12049642

    Corneal endothelial cells with increased cell density and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  7. US 11957754

    Clinical formulations

    Astellas Institute for Regenerative Medicine · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  8. US 11850261

    Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells

    Astellas Institute for Regenerative Medicine · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  9. US 11566228

    Hemangio-colony forming cells

    Astellas Institute for Regenerative Medicine · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  10. US 11400118

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  11. US 11241460

    Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells

    Astellas Institute for Regenerative Medicine · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  12. US 11013808

    Clinical formulations

    Astellas Institute for Regenerative Medicine · Granted May 25, 2021 · Expires May 20, 2041

    granted
  13. US 10894065

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted
  14. US 10584313

    Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere

    Astellas Institute for Regenerative Medicine · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  15. US 10485829

    Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells

    Astellas Institute for Regenerative Medicine · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  16. US 10426799

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  17. US 10307444

    Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells

    Astellas Institute for Regenerative Medicine · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  18. US 10077424

    Methods of producing RPE cells and compositions of RPE cells

    Astellas Institute for Regenerative Medicine · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  19. US 10072243

    Derivation of embryonic stem cells and embryo-derived cells

    Astellas Institute for Regenerative Medicine · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  20. US 9993503

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  21. US 9988602

    Methods for producing enucleated erythroid cells derived from pluripotent stem cells

    Astellas Institute for Regenerative Medicine · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  22. US 9938500

    Hemangio-colony forming cells

    Astellas Institute for Regenerative Medicine · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  23. US 9763984

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  24. US 9752118

    Method of directed differentiation producing corneal endothelial cells from neural crest stem cells by PDGFB and DKK2, compositions thereof, and uses thereof

    Astellas Institute for Regenerative Medicine · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted